Key facts
- It has raised $270K.
- Notable investors include Antler.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for alveos (Helsinki)
- ·The full record, as it builds
Funding rounds
No funding rounds for alveos (Helsinki) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About alveos (Helsinki)
Developer of an acoustic wearable designed to continuously capture and interpret breathing to support stress regulation, recovery, and overall nervous system monitoring. The company offers a proprietary respiratory-sensing platform and algorithms that generate novel breathing-based biomarkers, enabling consumer wellness users to access real-time insights that support breathwork, athletic performance, and daily stress management.
- Sector
- Healthcare
- HQ
- Helsinki, Finland
- Founded
- 2025
- Employees
- 6
- Website
- alveoslabs.com/
- Ownership
- Privately Held (backing)
alveos (Helsinki) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in alveos (Helsinki) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on alveos (Helsinki) in its N-PORT filings yet. We sweep new filings monthly.